Protective Effect of Methanolic Extract of Vernonia amygdalina (Bitter-Leaf) on Alloxan-Induced Pancreatic Toxicity in Adult Wistar Rats

Ozor, Christian Chiemeka and Anioba, Frank Onyedikachi and Ozoemena, Chiadikobi Lawrence (2023) Protective Effect of Methanolic Extract of Vernonia amygdalina (Bitter-Leaf) on Alloxan-Induced Pancreatic Toxicity in Adult Wistar Rats. Asian Journal of Research and Reports in Endocrinology, 6 (1). pp. 68-76.

[thumbnail of Ozoemena612023AJRRE98986.pdf] Text
Ozoemena612023AJRRE98986.pdf - Published Version

Download (859kB)

Abstract

The pancreas is a glandular organ endowed with two main functions; an exocrine function that assists digestion and an endocrine function that modulates blood glucose concentration. Pancreatic Beta-cells produce insulin to regulate/lower blood glucose concentration, driving them into cells to be utilized. Distortions of the architecture of pancreatic Beta-cells lead to function loss; thus, preservation/restoration of their cyto-architecture would sustain their functions. Vernonia amygdalina is a vital plant acknowledged widely for its antioxidant and anti-diabetic effects; however, its impact on the pancreas has received little attention. This study is premeditated to examine the effects of the methanolic leaf extracts of Vernonia amygdalina (MLEVA) on the cyto-architecture of the pancreas in Alloxan-induced pancreatic toxicity. Thirty (30) adult male Wistar rats were grouped into 6 (A-F) (n=5). Group A, the control group, received feed and water only. Group B received a single intra-peritoneal injection of 150mg/kg of Alloxan. Groups C, D, and E received single intra-peritoneal injections of 150mg/kg of Alloxan and were then treated with 200, 300, and 400 mg/kg/day of the MLEVA, respectively. Group F received a single intra-peritoneal injection of 150mg/kg of Alloxan and was orally treated with 100mg/kg/day of Vitamin E. The experiment lasted 16 days before sacrificing the animals via a median incision on the abdominal cavity, under ketamine (100mg/ml), as anaesthesia, 24 hours after their last treatment. The pancreas was carefully and rapidly processed for routine H & E staining. This study recorded a 28% mortality rate after Alloxan administration, leading to degenerative histo-pathological changes in the pancreas' endocrine and exocrine compartments. 300mg/kg of MLEVA demonstrated a marked regenerative effect on the pancreas. The MLEVA is a promising agent for managing Diabetes, evidenced by its protective and therapeutic effect on Alloxan-induced pancreatic toxicity.

Item Type: Article
Subjects: Article Paper Librarian > Medical Science
Depositing User: Unnamed user with email support@article.paperlibrarian.com
Date Deposited: 25 Apr 2023 12:01
Last Modified: 01 Mar 2024 04:16
URI: http://editor.journal7sub.com/id/eprint/767

Actions (login required)

View Item
View Item